Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2000 7
2001 8
2002 10
2003 6
2004 9
2005 5
2006 9
2007 15
2008 8
2009 8
2010 6
2011 2
2012 1
2013 2
2014 1
2015 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15220366

101 results

Results by year

Filters applied: . Clear all
Page 1
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.
Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Elisaf M. Athyros VG, et al. J Clin Pathol. 2004 Jul;57(7):728-34. doi: 10.1136/jcp.2003.012989. J Clin Pathol. 2004. PMID: 15220366 Free PMC article. Clinical Trial.
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
Athyros VG, Elisaf M, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Milionis HJ, Mikhailidis DP; GREACE Study Collaborative Group. Athyros VG, et al. Am J Kidney Dis. 2004 Apr;43(4):589-99. doi: 10.1053/j.ajkd.2003.12.023. Am J Kidney Dis. 2004. PMID: 15042535
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Mercouris BR, Pehlivanidis A, Bouloukos VI, Elisaf M; GREACE Collaborative Group. Athyros VG, et al. Curr Med Res Opin. 2004 May;20(5):627-37. doi: 10.1185/030079904125003421. Curr Med Res Opin. 2004. PMID: 15171226 Clinical Trial.
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG. Athyros VG, et al. Curr Med Res Opin. 2002;18(4):220-8. doi: 10.1185/030079902125000787. Curr Med Res Opin. 2002. PMID: 12201623 Clinical Trial.
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.
Athyros VG, Mikhailidis DP, Liberopoulos EN, Kakafika AI, Karagiannis A, Papageorgiou AA, Tziomalos K, Ganotakis ES, Elisaf M. Athyros VG, et al. Nephrol Dial Transplant. 2007 Jan;22(1):118-27. doi: 10.1093/ndt/gfl538. Epub 2006 Sep 23. Nephrol Dial Transplant. 2007. PMID: 16998214
Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Daskalopoulou SS, Kakafika AI, Pehlivanidis AN, Bouloukos VI, Langer A; GREACE Study Collaborative Group. Athyros VG, et al. Curr Med Res Opin. 2004 Sep;20(9):1385-92. doi: 10.1185/030079904125004484. Curr Med Res Opin. 2004. PMID: 15383187 Clinical Trial.
101 results